The Vendor Contract Your CRO Sent You Was Written to Protect Them, Not Your Data
Most deep tech founders sign CRO contracts without reading the IP and data ownership clauses. Here's what you're actually giving away.
W. Osei
Lab to Launch
From Bench to Business
Focus
Lab to Launch covers lab-to-market, startup commercialization, scrappy deep tech. We publish original analysis, frameworks, and commentary for practitioners and decision-makers.
Latest
W. OseiThe Clinical Trial Site You Picked Based on Relationships Will Blow Your Timeline
Choosing a clinical trial site because you know the PI is one of the most common and expensive mistakes early-stage medtech and biotech founders make.
W. OseiThe Reimbursement Code Your Medtech Startup Is Counting On Doesn't Exist Yet
Most medtech founders assume a CPT or ICD code will be waiting when they're ready to sell. Here's why that assumption will wreck your commercial timeline.
W. OseiThe Equity Split You Agreed to on a Napkin Will End Your Company in Year Three
That informal equity split you shook hands on feels fine now. Here's exactly why it becomes a catastrophic problem the moment real money shows up.
W. OseiThe Reference Customer You're About to Name in Your Pitch Deck Is Going to Call You a Liar
Before you put a customer logo in your pitch deck, understand exactly what that relationship actually means and what they'll say when investors call.
W. OseiThe Conflict of Interest Your Scientific Advisor Never Disclosed Will Torpedo Your Deal
Your scientific advisor's undisclosed competing interests can blow up a funding round or partnership deal. Here's what to find before it's too late.
W. Osei